logo
Select company
Select metric
$ 117.31MNet Cash Flow - Financing
VS
Market
15
Sector
12
Industry
15
History
9
$ 9.01Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 117.31M
3/31/2025$ 117.37M
12/31/2024$ 168.43M
9/30/2024$ 181.73M
6/30/2024$ 32.44M
3/31/2024$ 29.74M
12/31/2023$ -13.14M
9/30/2023$ -27.23M
6/30/2023$ -1.82M
3/31/2023$ 37.64M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 83.16M.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average CF - Financing has been $ 55.54M.
  • The median CF - Financing for CARTESIAN THERAPEUTICS INC during this period was $ 40.16M
  • CARTESIAN THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 181.73M.
  • The lowest CF - Financing recorded by CARTESIAN THERAPEUTICS INC in the same timeframe $ -27.23M

CARTESIAN THERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
HUMA : HUMACYTE INC $ 100.76MNWBO : NORTHWEST BIOTHERAPEUTICS INC $ 51.74MMREO : MEREO BIOPHARMA GROUP PLC $ -346KINBX : INHIBRX BIOSCIENCES INC $ 99.84MCRDF : CARDIFF ONCOLOGY INC $ 51.62MBTAI : BIOXCEL THERAPEUTICS INC $ 18.07MCATX : PERSPECTIVE THERAPEUTICS INC $ 11.08MADVM : ADVERUM BIOTECHNOLOGIES INC $ 359KSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ 7.09MLSTA : LISATA THERAPEUTICS INC $ -55K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

RNAC - Net Cash Flow - Financing, Last 5 years

$ -27.23M

Minimum

Sep 30, 2023

$ 181.73M

Maximum

Sep 30, 2024

$ 55.54M

Average

$ 40.16M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M